stableImportance 4/5Confidence 5/51 documented update

FDA Reins In Trump’s Hydroxychloroquine Hype

The FDA issued a new warning about hydroxychloroquine and chloroquine on April 24, saying the drugs can cause serious and potentially life-threatening heart rhythm problems and should be limited to clinical trials or certain hospitalized patients. That landed directly on top of Trump’s months-long habit of talking up the drug as a possible coronavirus fix. The agency’s warning was a blunt public correction to the president’s messaging. It also underscored how far the White House had drifted from evidence-based pandemic guidance.

Why it matters: Drug warning

First recorded Apr 24, 2020·Meaningfully updated Apr 24, 2020

Returning reader

Current status

No later development has been recorded. This evolving page currently contains the original verified report.

Complete record

Timeline

Newest first

Confidence 5/5

FDA Reins In Trump’s Hydroxychloroquine Hype

The FDA issued a new warning about hydroxychloroquine and chloroquine on April 24, saying the drugs can cause serious and potentially life-threatening heart rhythm problems and should be limited to clinical trials or certain hospitalized patients. That landed directly on top of Trump’s months-long habit of talking up the drug as a possible coronavirus fix. The agency’s warning was a blunt public correction to the pr…

Truth standard

What TDF can prove

The linked reports preserve their sources, audit notes, confidence rating, corrections, and comments. The page Q&A is restricted to those connected materials and will say when the evidence does not establish an answer.